Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial.

Häge A, Banaschewski T, Buitelaar JK, Dijkhuizen RM, Franke B, Lythgoe DJ, Mechler K, Williams SC, Dittmann RW; TACTICS Consortium.

Trials. 2016 Mar 17;17(1):141. doi: 10.1186/s13063-016-1266-8.

2.

NEUROBIOLOGICAL EVIDENCE SUPPORTING GLUTAMATE'S ROLE IN PEDIATRIC OBSESSIVE COMPULSIVE DISORDER.

MacMaster FP, Rosenberg DR.

Child Adolesc Psychopharmacol News. 2010 Dec;15(6):6-10. No abstract available.

3.

Striatal magnetic resonance spectroscopy abnormalities in young adult SAPAP3 knockout mice.

Mintzopoulos D, Gillis TE, Robertson HR, Dalia T, Feng G, Rauch SL, Kaufman MJ.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Jan 1;1(1):39-48.

PMID:
26858992
4.

From Thought to Action: How the Interplay Between Neuroscience and Phenomenology Changed Our Understanding of Obsessive-Compulsive Disorder.

Barahona-Corrêa JB, Camacho M, Castro-Rodrigues P, Costa R, Oliveira-Maia AJ.

Front Psychol. 2015 Nov 23;6:1798. doi: 10.3389/fpsyg.2015.01798. eCollection 2015. Review.

5.

Sertraline Treatment of Nonresponders to Extended Cognitive-Behavior Therapy in Pediatric Obsessive-Compulsive Disorder.

Skarphedinsson G, Weidle B, Ivarsson T.

J Child Adolesc Psychopharmacol. 2015 Sep;25(7):574-9. doi: 10.1089/cap.2015.0041. Epub 2015 Sep 8.

PMID:
26348088
6.

Glutamatergic agents for OCD and related disorders.

Pittenger C.

Curr Treat Options Psychiatry. 2015 Sep;2(3):271-283.

PMID:
26301176
7.

Glutamate modulators in the treatment of obsessive-compulsive disorder.

Pittenger C.

Psychiatr Ann. 2015 Jun;45(6):308-315.

PMID:
26236057
8.

In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept.

Rodriguez CI, Kegeles LS, Levinson A, Ogden RT, Mao X, Milak MS, Vermes D, Xie S, Hunter L, Flood P, Moore H, Shungu DC, Simpson HB.

Psychiatry Res. 2015 Aug 30;233(2):141-7. doi: 10.1016/j.pscychresns.2015.06.001. Epub 2015 Jun 6.

PMID:
26104826
9.

A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders.

Grados MA, Atkins EB, Kovacikova GI, McVicar E.

Psychol Res Behav Manag. 2015 Apr 28;8:115-31. doi: 10.2147/PRBM.S58601. eCollection 2015. Review.

10.

Dysfunctional Activation and Brain Network Profiles in Youth with Obsessive-Compulsive Disorder: A Focus on the Dorsal Anterior Cingulate during Working Memory.

Diwadkar VA, Burgess A, Hong E, Rix C, Arnold PD, Hanna GL, Rosenberg DR.

Front Hum Neurosci. 2015 Mar 17;9:149. doi: 10.3389/fnhum.2015.00149. eCollection 2015.

11.

Assessment of glutamate in striatal subregions in obsessive-compulsive disorder with proton magnetic resonance spectroscopy.

Simpson HB, Kegeles LS, Hunter L, Mao X, Van Meter P, Xu X, Kimeldorf MB, Pearlstein SL, Slifstein M, Shungu DC.

Psychiatry Res. 2015 Apr 30;232(1):65-70. doi: 10.1016/j.pscychresns.2015.01.009. Epub 2015 Feb 3.

12.

An Examination of Rostral Anterior Cingulate Cortex Function and Neurochemistry in Obsessive-Compulsive Disorder.

Brennan BP, Tkachenko O, Schwab ZJ, Juelich RJ, Ryan EM, Athey AJ, Pope HG, Jenike MA, Baker JT, Killgore WD, Hudson JI, Jensen JE, Rauch SL.

Neuropsychopharmacology. 2015 Jul;40(8):1866-76. doi: 10.1038/npp.2015.36. Epub 2015 Feb 9.

PMID:
25662837
13.
14.

Neuromodulation for obsessive-compulsive disorder.

Lapidus KA, Stern ER, Berlin HA, Goodman WK.

Neurotherapeutics. 2014 Jul;11(3):485-95. doi: 10.1007/s13311-014-0287-9. Review.

15.

Glutamate and the Treatment of Obsessive-Compulsive Disorder.

Macmaster FP, Rosenberg DR.

Psychopharm Rev. 2010 May 1;45(5):33-40. No abstract available.

16.

12-week, placebo-controlled trial of add-on riluzole in the treatment of childhood-onset obsessive-compulsive disorder.

Grant PJ, Joseph LA, Farmer CA, Luckenbaugh DA, Lougee LC, Zarate CA Jr, Swedo SE.

Neuropsychopharmacology. 2014 May;39(6):1453-9. doi: 10.1038/npp.2013.343. Epub 2013 Dec 19.

17.

The Genetics of Obsessive-Compulsive Disorder.

Bloch MH, Pittenger C.

Curr Psychiatry Rev. 2010 May 1;6(2):91-103.

18.

Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept.

Rodriguez CI, Kegeles LS, Levinson A, Feng T, Marcus SM, Vermes D, Flood P, Simpson HB.

Neuropsychopharmacology. 2013 Nov;38(12):2475-83. doi: 10.1038/npp.2013.150. Epub 2013 Jun 19.

19.

Isoforms of the neuronal glutamate transporter gene, SLC1A1/EAAC1, negatively modulate glutamate uptake: relevance to obsessive-compulsive disorder.

Porton B, Greenberg BD, Askland K, Serra LM, Gesmonde J, Rudnick G, Rasmussen SA, Kao HT.

Transl Psychiatry. 2013 May 21;3:e259. doi: 10.1038/tp.2013.35.

20.

Memantine: a review of possible uses in child and adolescent psychiatry.

Hosenbocus S, Chahal R.

J Can Acad Child Adolesc Psychiatry. 2013 May;22(2):166-71.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk